P&G Hygiene and Healthcare
Stock Snapshot
Price Performance
Vista Outlook
View Technicals Analysis →Basis of our Recommendation
Procter & Gamble Hygiene and Health Care (PGHH) is navigating a challenging environment characterized by persistent macro inflation and soft demand, which has led to a notable contraction in EBITDA margins. Management's focus on premiumization in the feminine hygiene segment and brand innovation is crucial for long-term growth, despite recent downward revisions in EPS estimates by analysts. Vista's financial outlook reflects moderated revenue growth and ongoing margin pressure, yet the company's conservative balance sheet and strategic investments position it for resilience. The personal care industry is witnessing improving pricing power, which could support PGHH's profitability. Over the next 12-24 months, key opportunities include leveraging productivity gains and enhancing brand loyalty through targeted communication, while watchpoints include the impact of evolving consumer behaviors and competitive pressures. Overall, Vista's forecast anticipates a stable growth trajectory, with a target price reflecting a modest upside potential
Why We Like This Stock
- Management's commitment to premiumization in the feminine hygiene segment is expected to enhance brand loyalty and market share
- The company's conservative balance sheet with low leverage supports financial stability amidst margin pressures
- Improving pricing power in the personal care industry may provide opportunities for margin recovery
Things To Watch Out For
- Persistent macro inflation and soft demand are leading to significant margin volatility and downward revisions in EPS estimates
- Competitive pressures from new entrants could challenge PGHH's market position and growth prospects
- The absence of immediate catalysts for revenue growth may hinder short-term performance
Key Parameters
Financial Snapshot
| Actuals | Forecast | ||||
|---|---|---|---|---|---|
| FY24 | FY25 | FY26 | FY27 | FY28 | |
| Revenue (Cr.) | 4,206 | 3,374 | 4,290 | 4,177 | 4,598 |
| Profit Before Tax (Cr.) | 945 | 862 | 1,167 | 1,108 | 1,227 |
| PBT Margin | 22.5% | 25.5% | 2720.3% | 26.5% | 26.7% |
| Net Profit (Cr.) | 681 | 645 | 867 | 819 | 908 |
| Earnings Per Share | 209.7 | 198.8 | 267.1 | 252.4 | 279.6 |
Analyst Recommendations
| Broker | Recommendation | Target Price | Date |
|---|---|---|---|
| Motilal Oswal | ► Neutral | 9,500 | 30-Jul-2026 |
Company Overview
Show Company Profile
Procter & Gamble Hygiene and Health Care Limited manufactures and sells branded packaged fast-moving consumer goods in the feminine care and healthcare businesses in India and internationally. It operates through Health care Products and Hygiene Products segments. The company offers health care products, including ointments and creams, cough drops, and tablets; and hygiene products, such as feminine hygiene and other skin care hygiene products, as well as feminine care pads. It also provides baby care products comprising nappies, pants, and baby wipes; grooming products; laundry products; hair care products; home, personal and skin care, and oral products. The company sells its products under the Vicks, Whisper, Pampers, Ariel, Tide, Gillette, Head & Shoulders, Herbal Essences, Pantene, Ambi Pur, Oral-B, Olay, and Old Spice brands through mass merchandisers, as well as grocery, membership club, drug, department, and high frequency stores. The company was incorporated in 1964 and is based in Mumbai, India. Procter & Gamble Hygiene and Health Care Limited operates as a subsidiary of The Procter & Gamble Company.